Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

<p>Supplementary Table 3 shows DEGs between ESCC primary tumors and matched lymph node metastatic tumors</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Chun-Miao Deng (15618965) (author)
Kolejni autorzy:	Guo-Geng Zhang (15618968) (author), Qin-Wen Liu (15618971) (author), Jiao-Jiao Xu (15618974) (author), Zhi-Chao Liu (15618977) (author), Jing Yang (15618980) (author), Tao-Yang Xu (15618983) (author), Zhi-Gang Li (15273287) (author), Fan Zhang (15618986) (author), Bin Li (14956623) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Cancer Biology Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Gastrointestinal Cancers Esophageal cancer Metabolism Metabolic pathways Oncogenes & Tumor Suppressors Oncogenes Progression, Invasion & Metastasis Metastasis Small Molecule Agents
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
od: Chun-Miao Deng (15618965)
Wydane: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
od: Xiaodong Shu (16721586)
Wydane: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
od: Jia Liu (15386858)
Wydane: (2025)

Figure 1 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
od: Angela Riedel (15130557)
Wydane: (2025)

Figure 2 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
od: Angela Riedel (15130557)
Wydane: (2025)

Figure 3 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
od: Angela Riedel (15130557)
Wydane: (2025)

Figure 4 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
od: Angela Riedel (15130557)
Wydane: (2025)

Figure 5 from Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma
od: Angela Riedel (15130557)
Wydane: (2025)

Table S1 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
od: Thomas Farge (15112135)
Wydane: (2025)

Table S2 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
od: Thomas Farge (15112135)
Wydane: (2025)

Table S3 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
od: Thomas Farge (15112135)
Wydane: (2025)

Table S4 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
od: Thomas Farge (15112135)
Wydane: (2025)

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
od: Xun-Xi Lu (14952883)
Wydane: (2025)

Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
od: Qiangsheng Hu (15400215)
Wydane: (2025)

Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
od: Qiangsheng Hu (15400215)
Wydane: (2025)

Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer
od: Sankar Jagadeeshan (15112900)
Wydane: (2025)

Supplementary Tables from The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression
od: Jing Tang (17314958)
Wydane: (2025)

Supplementary Data S1 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
od: Namhee Kim (14963603)
Wydane: (2025)

Supplementary Data S2 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States
od: Namhee Kim (14963603)
Wydane: (2025)

Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma.
od: Fengyi Mao (15073242)
Wydane: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
od: Min Wei (16918572)
Wydane: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
od: Min Wei (16918572)
Wydane: (2025)

Supplementary table S2 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Wydane: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4v7uvlffje57emh33hj5u9jr6c